{
    "BJOG - 2019 - Chu - Maternal Collapse in Pregnancy and the Puerperium.pdf": "1. Maternal Collapse\n2. Obstetric Modifed Early Warning Score\n3. Anaphylaxis Mast Cell Tryptase Levels\n4. Aortocaval Compression\n5. Resuscitation Council (UK) Guidelines\n6. Perimortem Caesarean Section (PMCS)\n7. Antepartum Haemorrhage\n8. Placental Abruption\n9. Amniotic Fluid Embolism (AFE)\n10. Intravenous Tranexamic Acid",
    "BJOG - 2019 - Thomson - Care of Women Presenting with Suspected Preterm Prelabour Rupture of Membranes from 24 0 Weeks of.pdf": "1. Preterm Prelabour Rupture of Membranes (PPROM)\n2. Sterile speculum examination\n3. Insulin-like growth factor-binding protein 1 (IGFBP-1)\n4. Placental alpha microglobulin-1 (PAMG-1)\n5. Erythromycin\n6. Corticosteroids\n7. Chorioamnionitis\n8. C-reactive protein\n9. White cell count\n10. Magnesium sulfate",
    "BJOG - 2022 - Shennan - Cervical Cerclage.pdf": "1. Cervical Cerclage\n2. Singleton pregnancies\n3. Preterm births\n4. Second trimester loss\n5. Ultrasound-indicated cerclage\n6. Transvaginal cerclage\n7. Transabdominal cerclage\n8. Cervical insufficiency\n9. Cervical length shortening\n10. Emergency cerclage",
    "BJOG - 2020 - Murphy - Assisted Vaginal Birth.pdf": "1. Assisted Vaginal Birth\n2. Epidural Analgesia\n3. Latent Phase of Labour\n4. Active Phase of Labour\n5. Rotational and Midpelvic Assisted Vaginal Birth\n6. Fetal Malposition\n7. Vacuum Extraction\n8. Subgaleal Haemorrhage\n9. Scalp Trauma\n10. Obstetric Anal Sphincter Injury (OASI)",
    "BJOG - 2016 -  - Diagnosis and Management of Ectopic Pregnancy.pdf": "1. Ectopic Pregnancy\n2. Tubal Pregnancy\n3. Transvaginal Ultrasound\n4. Serum progesterone level\n5. Serum beta-human chorionic gonadotrophin (b-hCG) level\n6. Cervical Pregnancy\n7. Caesarean Scar Pregnancy\n8. Interstitial Pregnancy\n9. Cornual Pregnancy\n10. Ovarian Pregnancy",
    "BJOG - 2022 - Stock - Antenatal corticosteroids to reduce neonatal morbidity and mortality.pdf": "1. Antenatal corticosteroids\n2. Neonatal morbidity\n3. Neonatal mortality\n4. Preterm birth\n5. Respiratory distress syndrome\n6. Planned caesarean birth\n7. Hypoglycaemia\n8. Developmental delay\n9. Preterm prelabour rupture of membranes (PPROM)\n10. Intraventricular haemorrhage.",
    "BHIVA-Pregnancy-guidelines-2020-3rd-interim-update.pdf.pdf": "1. HIV in pregnancy\n2. Postpartum management\n3. Antiretroviral therapy (ART)\n4. Vertical transmission of HIV\n5. Co-infection with other agents\n6. HIV-2\n7. Psychosocial care\n8. Breastfeeding\n9. Infant post-exposure prophylaxis (PEP)\n10. Hepatitis virus co-infections",
    "bjog-2018-jauniaux-placenta-praevia-and-placenta-accreta-diagnos.pdf": "1. Placenta Praevia\n2. Placenta Accreta\n3. Caesarean delivery\n4. Assisted reproductive technology\n5. Maternal smoking\n6. Low-lying placenta\n7. Transvaginal scanning (TVS)\n8. Cervical length measurement\n9. Antenatal corticosteroids\n10. Tocolytics",
    "BJOG - 2016 -  - Management of Premenstrual Syndrome.pdf": "1. Premenstrual Syndrome (PMS)\n2. Symptom diary\n3. Gonadotrophin-releasing hormone (GnRH) analogues\n4. Combined oral contraceptives (COCs)\n5. Selective serotonin reuptake inhibitors (SSRIs)\n6. Cognitive behavioural therapy (CBT)\n7. Drospirenone-containing COCs\n8. Percutaneous estradiol\n9. Levonorgestrel-releasing intrauterine system (LNG-IUS)\n10. Danazol",
    "NICE Guidance - 2023 - Ectopic.pdf": "1. Ectopic pregnancy\n2. Miscarriage\n3. Early pregnancy complications\n4. Early pregnancy assessment services\n5. Human chorionic gonadotropin (hCG) levels\n6. Recurrent miscarriage\n7. Molar pregnancy\n8. Haemodynamically unstable\n9. Amenorrhoea\n10. Tachycardia.",
    "BJOG - 2018 - Denison - Care of Women with Obesity in Pregnancy.pdf": "1. Obesity in Pregnancy\n2. Prepregnancy care\n3. Antenatal care\n4. Gestational weight gain\n5. Gestational diabetes\n6. Hypertensive complications\n7. Venous thromboembolism\n8. Mental health problems\n9. Chromosomal anomalies\n10. Fetal surveillance",
    "BMS-GUIDELINE-Management-of-unscheduled-bleeding-HRT-APRIL2024-F.pdf": "1. British Menopause Society\n2. Hormone Replacement Therapy (HRT)\n3. Post Reproductive Health\n4. Endometrial Cancer\n5. Sequential HRT (sHRT)\n6. Continuous Combined HRT (ccHRT)\n7. Risk Factors\n8. Transvaginal Ultrasound (TVS)\n9. Urgent Suspicion of Cancer Pathway (USCP)\n10. Polycystic Ovarian Syndrome (PCOS)",
    "antenatal-care-pdf-66143709695941.pdf": "1. Antenatal care\n2. NICE guideline\n3. Medicines and Healthcare products Regulatory Agency\n4. Yellow Card Scheme\n5. Venous thromboembolism\n6. Gestational diabetes\n7. Pre-eclampsia\n8. Breech presentation\n9. Symptomatic vaginal discharge\n10. Pelvic girdle pain",
    "BJOG - 2022 - Girling - Intrahepatic cholestasis of pregnancy.pdf": "1. Intrahepatic cholestasis of pregnancy (ICP)\n2. Itching in skin of normal appearance\n3. Raised peak random total bile acid concentration of 19 micromol/L or more\n4. Atypical clinical symptoms\n5. Relevant comorbidities\n6. Abnormal liver function tests\n7. Serum bile acid concentration is 100 micromol/L or more\n8. Risk of stillbirth\n9. Fetal ultrasound and/or cardiotocography (CTG)\n10. Obstetric Cholestasis",
    "BJOG - 2017 -  - Management of Inherited Bleeding Disorders in Pregnancy.pdf": "1. Inherited Bleeding Disorders\n2. Haemophilia\n3. Clotting factor VIII\n4. Clotting factor IX\n5. Genetic counselling\n6. Prenatal diagnosis\n7. Factor VIII/IX levels\n8. Tranexamic acid\n9. Desmopressin (DDAVP)\n10. Recombinant factor VIII/IX",
    "BJOG - 2017 -  - Management of Breech Presentation.pdf": "Diagnosis: Breech Presentation\n\nInvestigation: \n1. External cephalic version (ECV)\n2. Assessment for risk factors for a poorer outcome in planned vaginal breech birth\n3. Ultrasound to estimate the position of the fetal neck and legs, and the fetal weight \n4. Continuous electronic fetal monitoring \n\nManagement: \n1. Counselling on the risks and benefits of planned vaginal breech delivery versus planned caesarean section\n2. Individualised assessment of the long-term risks of caesarean section based on their individual risk profile and reproductive intentions\n3. Planned caesarean section for breech presentation in spontaneous preterm labour is not recommended\n4. Labour with a preterm breech should be managed as with a term breech\n5. Simulation equipment should be used to rehearse the skills that are needed during vaginal breech birth by all doctors and midwives\n6. Guidance for the case selection and management of vaginal breech birth should be developed in each department by the healthcare professionals who supervise such births\n7. Departments should consider developing a checklist to ensure comprehensive counselling of the woman regarding planned mode of delivery for babies presenting by the breech.",
    "NICE Quality Standard - 2018 - Endometriosis.pdf": "1. Endometriosis\n2. Quality standard\n3. Hormonal treatment\n4. Gynaecology service\n5. Abdominal examination\n6. Pelvic examination\n7. Chronic pelvic pain\n8. Deep endometriosis\n9. Specialist endometriosis service\n10. Patient experience.",
    "BJOG - 2016 -  - Management of Monochorionic Twin Pregnancy.pdf": "1. Monochorionic Twin Pregnancy\n2. Prenatal Ultrasound Chorionicity Allocation\n3. Twin-to-Twin Transfusion Syndrome (TTTS)\n4. Twin Anaemia-Polycythaemia Sequence (TAPS)\n5. Selective Growth Restriction (sGR)\n6. Fetoscopic Laser Ablation\n7. Quintero System\n8. Umbilical Artery Doppler Velocities\n9. Fetal Magnetic Resonance Imaging\n10. Monochorionic Monoamniotic (MCMA) Pregnancies",
    "BJOG - 2021 - Navaratnam - Amniocentesis and chorionic villus sampling.pdf": "1. Amniocentesis\n2. Chorionic villus sampling (CVS)\n3. Aneuploidy screening\n4. Cell free DNA testing\n5. Transabdominal CVS\n6. Transvaginal CVS\n7. Midtrimester amniocentesis\n8. Intra-amniotic infection\n9. Prophylactic anti D\n10. Non-invasive prenatal testing (NIPT)",
    "ca1_diagnostichysteroscopy19012011.pdf": "1. Diagnostic hysteroscopy\n2. General anaesthesia\n3. Endometrial biopsy\n4. Removal of polyp\n5. Insertion of levonorgestrel-releasing intrauterine system\n6. Treatment of fibroids\n7. Division of adhesions\n8. Obesity\n9. Pre-existing medical conditions\n10. Laparoscopy or laparotomy in the event of perforation.",
    "BJOG - 2020 -  Management of Gestational Trophoblastic Disease.pdf": "1. Gestational Trophoblastic Disease\n2. Molar pregnancies\n3. Hyperemesis\n4. Uterine enlargement\n5. Hyperthyroidism\n6. Pre-eclampsia\n7. Theca lutein cysts\n8. Metastatic disease\n9. Human chorionic gonadotrophin (hCG)\n10. Trophoblastic neoplasia",
    "ESHRE Guideline - 2022 - Endometriosis.pdf": "1. ESHRE Endometriosis Guideline Development Group\n2. European Society of Human Reproduction and Embryology\n3. Clinical practice guideline\n4. Healthcare professionals\n5. Endometriosis\n6. Clinical recommendations\n7. Clinical judgment\n8. Healthcare delivery\n9. Patient population\n10. Clinical decisions",
    "BJOG - 2017 -  - Prevention of Early\u2010onset Neonatal Group B Streptococcal Disease.pdf": "1. Early-onset Neonatal Group B Streptococcal Disease\n2. Group B streptococcal (GBS) colonisation\n3. Antenatal screening\n4. Intrapartum antibiotic prophylaxis (IAP)\n5. GBS bacteriuria\n6. GBS urinary tract infection\n7. Maternal GBS carriage\n8. Preterm labour\n9. Polymerase chain reaction\n10. Early-onset neonatal infection",
    "BJOG - 2017 -  - External Cephalic Version and Reducing the Incidence of Term Breech Presentation.pdf": "Diagnosis:\n- Term Breech Presentation\n- Noncephalic birth\n\nInvestigation:\n- External Cephalic Version (ECV)\n- ECV success prediction models\n- Use of tocolysis with betamimetics\n- Use of regional analgesia or neuraxial blockade\n- Testing for fetomaternal haemorrhage\n\nManagement:\n- ECV should be offered at term from 37+0 weeks of gestation\n- In nulliparous women, ECV may be offered from 36+0 weeks of gestation\n- ECV should only be performed by a trained practitioner or by a trainee working under direct supervision\n- ECV should be performed where facilities for monitoring and surgical delivery are available\n- Following ECV, Electronic Fetal Monitoring (EFM) is recommended\n- Women undergoing ECV who are D negative should be offered anti-D\n- Consideration of the use of moxibustion for breech presentation at 33 \u201335 weeks of gestation, under the guidance of a trained practitioner\n- No evidence that postural management alone promotes spontaneous version to cephalic presentation.",
    "BJOG - 2016 -  - Prevention and Management of Postpartum Haemorrhage.pdf": "1. Postpartum haemorrhage (PPH)\n2. Antenatal anaemia\n3. Uterine massage\n4. Prophylactic uterotonics\n5. Oxytocin\n6. Ergometrine\n7. Intravenous tranexamic acid\n8. Clinical shock\n9. Intravenous access\n10. Fibrinogen replacement",
    "BJOG - 2016 -  - Management of Bladder Pain Syndrome.pdf": "1. Bladder Pain Syndrome (BPS)\n2. Urinary Tract Infection (UTI)\n3. Urological Malignancy\n4. Urinary Ureaplasma\n5. Chlamydia\n6. Overactive Bladder\n7. Stress Urinary Incontinence\n8. Voiding Dysfunction\n9. Hunner Lesions\n10. Neuromodulation"
}